Travere Therapeutics (TVTX) Enterprise Value Growth (1y) (2014 - 2026)
Travere Therapeutics (TVTX) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.60% |
| Dec 31, 2025 | -58.94% |
| Sep 30, 2025 | -204.68% |
| Jun 30, 2025 | -132.74% |
| Mar 31, 2025 | -43.11% |
| Dec 31, 2024 | -0.62% |
| Sep 30, 2024 | 74.76% |
| Jun 30, 2024 | 54.44% |
| Mar 31, 2024 | 73.20% |
| Dec 31, 2023 | 5.69% |
| Sep 30, 2023 | 4.69% |
| Jun 30, 2023 | 60.57% |
| Mar 31, 2023 | 37.10% |
| Dec 31, 2022 | 62.78% |
| Sep 30, 2022 | -0.67% |
| Jun 30, 2022 | -115.83% |
| Mar 31, 2022 | -73.09% |
| Dec 31, 2021 | -95.53% |
| Sep 30, 2021 | 25.02% |
| Jun 30, 2021 | 64.88% |